A Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effect of Various Fixed-Dose Leucine and Metformin Combinations (NS-0100) Versus Standard Metformin Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Leucine/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 18 May 2016 According to a NuSirt Biopharma media release, data from this trial will be presented at the American Diabetes Association's 76th Scientific Sessions.
- 26 Jan 2016 Status changed from active, no longer recruiting to completed, according to a NuSirt Biopharma media release.
- 26 Jan 2016 Results published in a NuSirt Biopharma media release.